ASN-400

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameASN-400
Drug Alias NameStreptococcus pneumoniae mAbs (Arsanis/Adimab)ASN-400
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustria
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX4 Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPneumococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A